Title : L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs.

Pub. Date : 1987 Nov-Dec

PMID : 3441445






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs. Devazepide cholecystokinin Canis lupus familiaris
2 L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs. Devazepide cholecystokinin Canis lupus familiaris
3 This study demonstrates that L364718 acts as a potent antagonist of CCK"s action on pancreatic enzyme secretion and PP release in dogs and suggests that this agent might be a useful tool for studying the physiological role of CCK in conscious animals. Devazepide cholecystokinin Canis lupus familiaris
4 This study demonstrates that L364718 acts as a potent antagonist of CCK"s action on pancreatic enzyme secretion and PP release in dogs and suggests that this agent might be a useful tool for studying the physiological role of CCK in conscious animals. Devazepide cholecystokinin Canis lupus familiaris